Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/38196
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGlynne-Jones R.en
dc.contributor.authorBridgewater J.en
dc.contributor.authorFalk S.en
dc.contributor.authorArnold D.en
dc.contributor.authorCunningham D.en
dc.contributor.authorRao S.en
dc.contributor.authorSclafani F.en
dc.contributor.authorEng C.en
dc.contributor.authorGronlie Guren M.en
dc.contributor.authorAdams R.A.en
dc.contributor.authorBenson A.en
dc.contributor.authorSebag-Montefiore D.en
dc.contributor.authorSegelov E.en
dc.contributor.authorBryant A.en
dc.contributor.authorPeckitt C.en
dc.contributor.authorRoy A.en
dc.contributor.authorSeymour M.T.en
dc.contributor.authorWelch J.en
dc.contributor.authorSaunders M.P.en
dc.contributor.authorMuirhead R.en
dc.date.accessioned2021-05-14T13:01:05Zen
dc.date.available2021-05-14T13:01:05Zen
dc.date.copyright2018en
dc.date.created20200318en
dc.date.issued2020-03-18en
dc.identifier.citationAnnals of oncology : official journal of the European Society for Medical Oncology. 29 (Supplement 8) (pp viii715-viii716), 2018. Date of Publication: 01 Oct 2018.en
dc.identifier.issn1569-8041 (electronic)en
dc.identifier.urihttps://repository.monashhealth.org/monashhealthjspui/handle/1/38196en
dc.languageenen
dc.publisherNLM (Medline)en
dc.relation.ispartofAnnals of Oncology-
dc.subject.meshphase 2-
dc.subject.meshcarboplatin-
dc.subject.meshcisplatin-
dc.subject.meshfluorouracil-
dc.subject.meshpaclitaxel-
dc.subject.meshadvanced cancer-
dc.subject.meshanus cancer-
dc.subject.meshcancer recurrence-
dc.titleInterAACT: A multicentre open label randomised phase II advanced anal cancer trial of cisplatin (CDDP) plus 5-fluorouracil (5-FU) vs carboplatin (C) plus weekly paclitaxel (P) in patients (pts) with inoperable locally recurrent (ILR) or metastatic treatment naive disease - An International Rare Cancers Initiative (IRCI) trial.en
dc.typeArticleen
dc.identifier.affiliationOncology-
dc.type.studyortrialRandomised controlled trial-
dc.identifier.doihttp://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1093/annonc/mdy424.022-
dc.publisher.placeUnited Kingdomen
dc.identifier.pubmedid32137981 [http://www.ncbi.nlm.nih.gov/pubmed/?term=32137981]en
dc.identifier.source631210399en
dc.identifier.institution(Rao, Bryant) GI Unit, Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom (Sclafani) Medicine-GI & Lymphoma Unit, Institute of Cancer Research/Royal Marsden NHS Foundation Trust, Sutton, United Kingdom (Eng) Department of Gastrointestinal Medical Oncology, M. D. Anderson Cancer Center, TX, Houston, United States (Gronlie Guren) GI Unit, Oslo University Hospital, Oslo, Norway (Adams) Division of Cancer and Genetics, Cardiff University, Cardiff, United Kingdom (Benson) Medicine, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, United States (Sebag-Montefiore) GI Unit, University of Leeds, Leeds, United Kingdom (Segelov) Oncology, Monash Medical Centre, Clayton, Australia (Peckitt) R&D, Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom (Roy) GI Unit, Flinders Centre for Innovation in Cancer, Bedford Park, Australia (Seymour) Medical Oncology, St. James's University Hospital Leeds, Leeds, United Kingdom (Welch) Center for Global Health, NY, NY, United States (Saunders) GI Unit, Christie NHS Foundation Trust, Manchester, United Kingdom (Muirhead) Oncology, Churchill Hospital, Oxford, United Kingdom (Bridgewater) Oncology, University College London Hospitals, London, United Kingdom (Falk) Bristol Haematology and Cancer Centre, Bristol University Hospitals NHS Foundation Trust, Bristol, United Kingdom (Glynne-Jones) Radiotherapy, Mount Vernon Cancer Centre, Northwood, United Kingdom (Arnold) 2. Med. Abteilung, Asklepios Klinik Altona, Hamburg, Germany (Cunningham) Medicine, Institute of Cancer Research/Royal Marsden NHS Foundation Trust, Sutton, United Kingdomen
dc.rights.statementThis record is sourced from MEDLINE/PubMed, a database of the U.S. National Library of Medicineen
dc.identifier.affiliationext(Rao, Bryant) GI Unit, Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom-
dc.identifier.affiliationext(Sclafani) Medicine-GI & Lymphoma Unit, Institute of Cancer Research/Royal Marsden NHS Foundation Trust, Sutton, United Kingdom-
dc.identifier.affiliationext(Eng) Department of Gastrointestinal Medical Oncology, M. D. Anderson Cancer Center, TX, Houston, United States-
dc.identifier.affiliationext(Gronlie Guren) GI Unit, Oslo University Hospital, Oslo, Norway-
dc.identifier.affiliationext(Adams) Division of Cancer and Genetics, Cardiff University, Cardiff, United Kingdom-
dc.identifier.affiliationext(Benson) Medicine, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, United States-
dc.identifier.affiliationext(Sebag-Montefiore) GI Unit, University of Leeds, Leeds, United Kingdom-
dc.identifier.affiliationext(Peckitt) R&D, Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom-
dc.identifier.affiliationext(Roy) GI Unit, Flinders Centre for Innovation in Cancer, Bedford Park, Australia-
dc.identifier.affiliationext(Seymour) Medical Oncology, St. James's University Hospital Leeds, Leeds, United Kingdom-
dc.identifier.affiliationext(Welch) Center for Global Health, NY, NY, United States-
dc.identifier.affiliationext(Saunders) GI Unit, Christie NHS Foundation Trust, Manchester, United Kingdom-
dc.identifier.affiliationext(Muirhead) Oncology, Churchill Hospital, Oxford, United Kingdom-
dc.identifier.affiliationext(Bridgewater) Oncology, University College London Hospitals, London, United Kingdom-
dc.identifier.affiliationext(Falk) Bristol Haematology and Cancer Centre, Bristol University Hospitals NHS Foundation Trust, Bristol, United Kingdom-
dc.identifier.affiliationext(Glynne-Jones) Radiotherapy, Mount Vernon Cancer Centre, Northwood, United Kingdom-
dc.identifier.affiliationext(Arnold) 2. Med. Abteilung, Asklepios Klinik Altona, Hamburg, Germany-
dc.identifier.affiliationext(Cunningham) Medicine, Institute of Cancer Research/Royal Marsden NHS Foundation Trust, Sutton, United Kingdom-
dc.identifier.affiliationmh(Segelov) Oncology, Monash Medical Centre, Clayton, Australia-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.grantfulltextnone-
item.openairetypeArticle-
crisitem.author.deptOncology-
Appears in Collections:Articles
Show simple item record

Page view(s)

174
checked on May 27, 2025

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.